fotemustine has been researched along with Local Neoplasm Recurrence in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 12 (40.00) | 29.6817 |
| 2010's | 15 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldaccini, D; Bazzoli, E; Bocci, G; Cantarella, M; Catania, F; Delishaj, D; Fabi, A; Fabrini, MG; Franchino, F; Gonnelli, A; Lolli, I; Lombardi, G; Molinari, A; Montrone, S; Morganti, R; Pace, A; Paiar, F; Pasqualetti, F; Pellerino, A; Rudà, R; Soffietti, R; Villani, V; Vivaldi, C; Zagonel, V | 1 |
| Buonerba, C; Cerbone, L; Cordua, N; De Placido, S; Di Lorenzo, G; Lamberti, G; Marinelli, A; Peluso, G | 1 |
| Berardi, R; Burattini, L; Cascinu, S; Detti, B; Fabrini, MG; Iacovelli, R; Lolli, I; Perrone, F; Santoni, M; Savio, G; Scoccianti, S; Silvano, G | 1 |
| Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A; Simonetti, G | 1 |
| Bertero, L; Cassoni, P; Castiglione, A; Ciccone, G; Fabrini, MG; Lolli, I; Morra, I; Pasqualetti, F; Rudà, R; Soffietti, R; Trevisan, E | 1 |
| Carapella, CM; Carosi, MA; Cognetti, F; Fabi, A; Giannarelli, D; Marucci, L; Metro, G; Pace, A; Piludu, F; Pompili, A; Telera, S; Vaccaro, V; Vari, S; Vidiri, A; Villani, V | 1 |
| Christmann, M; Kaina, B; Krumm, A; Loquai, C; Merz, S; Quiros, S; Roos, WP; Switzeny, OJ | 1 |
| Lai, T; Lian, L; Liu, D; Liu, J; Liu, Z; Wang, J; Zhang, G; Zhu, L; Zhuang, X | 1 |
| Benavides, M; Berros, JP; Cano, JM; Ceballos, I; Covela, M; Fernández, I; Fuster, J; García Bueno, JM; García, A; Manneh, R; Moreno, V; Pérez-Segura, P; Quintanar, T; Sepúlveda, J; Vaz, MA | 1 |
| Agati, R; Brandes, AA; Caserta, C; Clavarezza, M; Eoli, M; Eusebi, V; Fabi, A; Finocchiaro, G; Franceschi, E; Lombardi, G; Maiello, E; Monteforte, M; Proietti, E; Reni, M; Zagonel, V | 1 |
| Bellu, L; D'Avella, D; Della Puppa, A; Farina, M; Fiduccia, P; Lombardi, G; Pambuku, A; Zagonel, V | 1 |
| Ammannati, F; Biti, G; Bordi, L; Borghesi, S; Detti, B; Iannalfi, A; Leonulli, BG; Martinelli, F; Meattini, I; Sardaro, A; Scoccianti, S | 1 |
| Cionini, L; Fabrini, MG; Lolli, I; Marsella, A; Perrone, F; Scotti, V; Silvano, G | 1 |
| Carapella, CM; Carosi, M; Cognetti, F; Fabi, A; Jandolo, B; Maschio, M; Metro, G; Mirri, MA; Pace, A; Russillo, M; Sperduti, I; Telera, S; Vidiri, A | 1 |
| Addeo, R; Caraglia, M; De Santi, MS; Del Prete, S | 1 |
| Ferri-Níguez, B; González-Tortosa, J; Ros de San Pedro, J | 1 |
| Carapella, CM; Carosi, M; Cognetti, F; Fabi, A; Lanzetta, G; Maschio, M; Metro, G; Pace, A; Russillo, M; Sperduti, I; Telera, S; Vidiri, A | 1 |
| Abbruzzese, A; Addeo, R; Caraglia, M; Carraturo, M; Cennamo, G; De Santi, MS; Del Prete, S; Faiola, V; Genovese, M; Montella, L; Parlato, C; Vincenzi, B | 1 |
| Botturi, A; Ferrari, D; Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A; Simonetti, G | 1 |
| Bonizzoni, E; Detti, B; Fabrini, MG; Lolli, I; Paccapelo, A; Perrone, F; Perrone, T; Santoni, M; Savio, G; Scoccianti, S; Silvano, G | 1 |
| Binder, B; Cerroni, L; Kerl, H; Richtig, E; Smolle, J; Wolf, IH | 1 |
| Dieckmann, K; Fazeny-Dörner, B; Marosi, C; Piribauer, M; Rössler, K; Ungersböck, K; Veitl, M; Wenzel, C | 1 |
| Bonenkamp, JJ; de Faria Lima, R; de Wilt, JH; Doubrovsky, A; Kam, PC; Thompson, JF | 1 |
| Audra, P; Cartalat-Carel, S; Colin, P; Ducray, F; Gaucherand, P; Honnorat, J; Mahla, K; Pelissou-Guyotat, I; Trouillas, P | 1 |
| Boiardi, A; Botturi, A; Eoli, M; Falcone, C; Filippini, G; Fiumani, A; Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A | 1 |
| Dam-Hieu, P; Labat, JP; Lucas, B; Malhaire, JP; Person, H; Simon, H | 1 |
| Berger, E; Boiardi, A; Ciusani, E; Giroux, B; Lucas, C; Margison, G; Silvani, A; Watson, A | 1 |
| Cagli, S; Dalbasti, T; Oktar, N; Ozdamar, N | 1 |
| Derlon, JM; Frenay, M; Giroux, B; Khoury, S; Namer, M | 1 |
| Berille, J; Bizzari, JP; Jacquillat, C; Khayat, D; Spielmann, M; Tursz, T | 1 |
1 review(s) available for fotemustine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Cerebellopontine angle meningeal melanocytoma: a benign tumor?].
Topics: Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Cerebellopontine Angle; Diagnosis, Differential; Disease Progression; Fatal Outcome; Gait Disorders, Neurologic; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Melanocytes; Melanoma; Meningeal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neurilemmoma; Nevus; Nitrosourea Compounds; Organophosphorus Compounds | 2009 |
14 trial(s) available for fotemustine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Glioblastoma; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide; Thrombocytopenia | 2018 |
Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2013 |
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology).
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neurologic Examination; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Survival Analysis; Time Factors; Tumor Suppressor Proteins | 2014 |
Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate | 2014 |
AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Survival Rate | 2016 |
Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.
Topics: Adult; Aged; Brain Neoplasms; Dacarbazine; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Prospective Studies; Temozolomide | 2008 |
A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds | 2009 |
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Female; Glioma; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Promoter Regions, Genetic; Tumor Suppressor Proteins | 2010 |
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Confidence Intervals; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Odds Ratio; Organophosphorus Compounds; Temozolomide; Time Factors; Tomography, X-Ray Computed | 2011 |
Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Salvage Therapy; Survival Rate | 2003 |
Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Procarbazine; Salvage Therapy; Temozolomide | 2008 |
Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Lymphocytes; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Procarbazine | 2001 |
Local interstitial chemotherapy with sustained release bucladesine in de novo glioblastoma multiforme: a preliminary study.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Bucladesine; Delayed-Action Preparations; Drug Implants; Drug Therapy, Combination; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection; Survival Rate | 2002 |
[Fotemustine: a pilot phase II trial in sarcoma of the soft tissues].
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Sarcoma; Soft Tissue Neoplasms | 1991 |
15 other study(ies) available for fotemustine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2018 |
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2013 |
B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dacarbazine; Drug Synergism; Humans; Indoles; Melanoma; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Proto-Oncogene Proteins B-raf; Sulfonamides; Temozolomide; Vemurafenib | 2014 |
Retrospective analysis of bevacizumab in combination with fotemustine in chinese patients with recurrent glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bevacizumab; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Retrospective Studies; Young Adult | 2015 |
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Administration Schedule; Female; Humans; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2016 |
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation.
Topics: Adult; Aged; Antineoplastic Agents; DNA Methylation; Dose-Response Relationship, Drug; Follow-Up Studies; Glioma; Humans; Karnofsky Performance Status; Middle Aged; Multivariate Analysis; Nausea; Neoplasm Recurrence, Local; Neutropenia; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Promoter Regions, Genetic; Retrospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting | 2009 |
Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Glioblastoma; Humans; Methylation; Neoplasm Recurrence, Local; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Promoter Regions, Genetic; Randomized Controlled Trials as Topic | 2009 |
Lecture: fotemustine in brain tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Glioblastoma; Humans; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds | 2011 |
A retrospective pooled analysis of response patterns and risk factors in recurrent malignant glioma patients receiving a nitrosourea-based chemotherapy.
Topics: Adult; Aged; Brain Neoplasms; Dacarbazine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Risk Factors; Temozolomide; Time Factors; Treatment Failure | 2012 |
Topical imiquimod in the treatment of metastatic melanoma to skin.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Knee; Leg; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Scalp; Skin Neoplasms; Treatment Outcome | 2003 |
Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Dacarbazine; Follow-Up Studies; Humans; Limb Salvage; Lower Extremity; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Remission Induction; Salvage Therapy; Skin Neoplasms; Treatment Outcome | 2004 |
[Management of malignant gliomas diagnosed during pregnancy].
Topics: Abortion, Therapeutic; Adrenal Cortex Hormones; Adult; Algorithms; Anesthesia, General; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbamazepine; Carmustine; Case Management; Cesarean Section; Chemotherapy, Adjuvant; Cranial Irradiation; Craniotomy; Dacarbazine; Female; Frontal Lobe; Glioblastoma; Humans; Infant, Newborn; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Paresis; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects; Radiotherapy, Adjuvant; Remission Induction; Supratentorial Neoplasms; Temozolomide; Temporal Lobe | 2006 |
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas].
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds | 1999 |
Phase II study of fotemustine in recurrent supratentorial malignant gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain; Drug Evaluation; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Supratentorial Neoplasms | 1991 |